OpenAlex
PricingAboutJobs
Log inGet started
Work

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

HTML

Year: 2000
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.9.12.2903
Author: Lloyd R Kelland
Institution: Institute of Cancer Research
Language: English

Topic: Cancer-related Molecular Pathways
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: flavopiridol, cyclin-dependent kinase inhibitors, CDK1, CDK2, CDK4, prostate cancer, head and neck cancer, non-Hodgkin lymphoma, leukemia, paclitaxel combination therapy, cisplatin combination therapy, antitumour activity, pharmacokinetics, glucuronidation, drug toxicity, apoptosis, P-TEFb, aldehyde dehydrogenase, glycogen phosphorylase
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2153640566
FWCI: 1.198
Cites: 38
Cited by: 141
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security